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Abstract
Background: The incidence of type 1 diabetes is increasing worldwide. Since so little is known about work
life of individuals with type 1 diabetes, we examined incidence and prevalence trends of type 1 diabetes
among working-aged Finns. We also investigated the employment rate and how workers with type 1
diabetes perceive their health and work ability, and their intended retirement age.
Methods: We analyzed changes in the incidence, prevalence, and employment rate using nationwide multi-
register-based FinDM data, and estimated a Self-Rated Health, Work Ability Score, and inquired about
retirement intentions of 767 working individuals with type 1 diabetes in a cross-sectional survey. All estimates
were compared to the corresponding data of the Finnish general population.
Results: The average annual age-standardized incidence rate of type 1 diabetes among men aged 18–39
was 29 per 100,000/year; the incidence rate has increased by 33% from 1992 to 2007. Among women, the
incidence remained at 16 per 100,000/year. Among working-aged (18–64) people, the age-standardized prevalence
of type 1 diabetes increased by 39% among women and 33% among men. Two out of every three working aged
individuals with type 1 diabetes were in the labor force; this is about 10% lower than in the Finnish population. The
average age-standardized employment rate among those individuals with type 1 diabetes belonging to the labor
force was 82%, compared to 84% in the general population. Working individuals with type 1 diabetes rated their
health and work ability as being slightly lower than the general working population, but nonetheless, there were
no significant differences in retirement intentions.
Conclusions: Between 1992 and 2007, the number of working-aged people and workers with type 1 diabetes
increased by 35%. Most workers with type 1 diabetes manage as well at work as the general population. Special
attention should be paid to workers with type 1 diabetes when they are diagnosed and/or report moderate or
poor work ability.
Keywords: Type 1 diabetes, Incidence, Prevalence, Employment, Work, Self-rated health, Work ability, Retirement,
Occupational health care, Finland
Background
The incidence of type 1 diabetes has increased globally
on average by 3–5% per year [1]. Finland has the highest
rate of type 1 diabetes in the world [2, 3]. Between 2006
−2011, the mean incidence of type 1 diabetes in children
under 15 years was 62.5 per 100,000/year [4]. In all, there
are about 50,000 people with type 1 diabetes in Finland, i.e.
0.9% of the total population [5, 6]. They represent about
15% of the prevalent diagnosed cases of diabetes in
Finland [7].
In type 1 diabetes, the blood glucose level tends to be
elevated. However, insuIin administration, which is used
to regulate the blood glucose level, may predispose the
individual to hypoglycaemia [8, 9]. A worker with type 1
diabetes has to ensure that his/her blood glucose level
remains optimal during the working hours [9]. Optimal
control of blood glucose levels is not only important in
the short term, it is also necessary to avoid severe long-term
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pathological outcomes i.e. diabetic kidney and eye diseases,
diabetic neuropathy and cardiovascular diseases, all of which
exert a profound effect on an individual's health [8, 9].
The above-mentioned health-related issues including
hypoglycaemia, hyperglycaemia and other complications
can impair the individual’s functional capacity, have medical
and financial consequences as well as reducing his/her so-
cial well-being and quality of life [10–13]. Even non-severe
hypoglycaemic events can weaken a worker’s ability to man-
age his/her duties and require time off work [10]. In
addition, it has been shown that severe hypoglycaemia and
diabetes-related complications are associated with discrim-
ination in the workplace [14] and early retirement [15]. Fur-
thermore, these health-related complications have been a
reason for changing the workplace, even unemployment
[12, 16]. Finally, considerable overall excess mortality has
been found in individuals with insulin-treated diabetes [17].
Some of the previous studies of employment among
individuals with type 1 diabetes have suggested that indi-
viduals with type 1 diabetes may be less likely to be
employed than the general population [13]. However,
there is no consensus as there are some reports where
the situation is opposite [18] and one report which
found no difference between individuals with type 1 dia-
betes and the general population [19].
Type 1 diabetes is costly for the society. For instance, in
the UK, direct healthcare costs of type 1 diabetes have been
estimated to consume more than 1% of the healthcare
budget [20]. Diabetes-related complications are responsible
for a major proportion of direct health expenditures. In
addition to direct healthcare costs, diabetes also exerts a
major influence via indirect costs, mainly attributable to re-
duced productivity linked with premature death, early re-
tirement, absenteeism and presenteeism [20, 21].
Little research has been conducted on the employment
rate of people with type 1 diabetes and their work life
[13, 22, 23], although this kind of information is very
important to employers and societies when trying to
keep a high proportion of the work force in work and
postponing premature retirement.
In 2011, the number of working-aged people with type 1
diabetes in Finland was around 30,000 [National Institute
for Health and Welfare (THL). Diabetes in Finland (FinDM),
2011. Unpublished database]. It is not known how many of
them are working and how these numbers have changed in
recent years. It is also not known how people with type 1
diabetes rate their health, work ability, and intended retire-
ment age in comparison to the general working population.
First, we aimed to determine incidence and prevalence
trends of type 1 diabetes among working-aged Finns. Next,
we investigated the proportion of working-aged Finns with
type 1 diabetes belonging to the labor force and calculated
their employment rates in comparison with an aged-
matched general Finnish population. Finally, we assessed
how working Finns with type 1 diabetes perceive their health
and work ability, and asked them about their intended retire-
ment age which we compared to the general population’s.
Methods
Two national diabetes studies
This study is based on two national diabetes studies con-
ducted in Finland. The FinDM database covers all people
with diabetes since 1964. Individuals with type 1 diabetes
were identified from several Finnish national registers
[24]. We used a version of the database that was linked to
employment data covering people with diabetes from
1964 until 2007. Data on the labor force and employment
were obtained from the Employment Statistics maintained
by Statistics Finland and individually linked to the FinDM
data for the 1992–2007 period using the unique personal
identification codes. Those belonging to the labor force
were defined as employed or unemployed during the last
week of the previous calendar year. Those not included in
the labor force included students and pupils, pensioners,
military conscripts and other special groups [25].
The “People with Type 1 Diabetes in Worklife” survey
was implemented by the University of Eastern Finland and
Kuopio University Hospital. This national survey was carried
out by sending a postal questionnaire to a random sample
of 2500 people with type 1 diabetes aged 18–65 years from
the Medication Reimbursement Register of the Social Insur-
ance Institution of Finland. Out of the sample of 2500, 1214
subjects with type 1 diabetes returned the form, a response
rate of 49%.The data were collected cross-sectionally in
2010–2011. This project has been described elsewhere [26].
Identifying people with type 1 diabetes
FinDM: On the basis of the register data, people with type
1 diabetes (insulin-dependent diabetes) were identified
using data based on their need for antidiabetic medication.
It was assumed that in practice all individuals with type 1
diabetes were under the age of 40 at the diagnosis date and
had required constant insulin therapy since the diagnosis of
diabetes, and that they did not use oral antidiabetic drugs
intended to increase pancreatic insulin secretion [24].
The “People with Type 1 Diabetes in Worklife” survey:
According to the Medication Reimbursement Register of
the Social Insurance Institution of Finland, the partici-
pants in this survey had type 1 diabetes. If a participant
confirmed having a type 1 diabetes diagnosis, he/she was
accepted into the study.
Measurements
“People with Type 1 Diabetes in Worklife” survey: the
sociodemographic variables in the survey included gen-
der, age, marital status, and education. The questions
concerning diabetes queried the duration of diabetes (classi-
fied as 0–5, 6–10, 11–15, and >16 years), and last checked
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HbA1c (glycosylated hemoglobin) level (1 = ≤60 mmol/mol
(≤7.5%); 2 = 61–70 mmol/mol (7.6–8.5%); 3 = 71–80 mmol/
mol (8.6–9.5%); 4 = ≥81 mmol/mol (≥9.6%). In addition, the
respondents were asked: “Have you had hypoglycemic events
in which help has been needed during the last 12 months?”
Severe hypoglycemic events in the past 12 months were
rated on a scale of 0–2 (no; once; twice or more often).
Self-rated health
Self-Rated Health (SRH) is one of the most frequently used
measures of general health in epidemiological studies [27,
28]. SRH was assessed by asking the question “How would
you assess your present state of health?”. Respondents rated
their current perceived health on a scale of 1–5 (1 = good;
2 = reasonably good; 3 = average; 4 = rather poor; 5 = poor)
[29]. The SRH of Finnish working individuals aged 18–
64 years with type 1 diabetes was compared to the data of
the working general population of the same age in Finland.
The previously unpublished population-level comparison
data of working Finnish people from 2010 was obtained for
SRH from the National Institute for Health and Welfare
[National Institute for Health and Welfare (THL). Health
Behaviour and Health among the Finnish Adult Population,
Spring 2010 survey. Unpublished database].
“Health Behaviour and Health among the Finnish Adult
Population (AVTK)” was conducted by the National Institute
for Health and Welfare. The survey monitored health and
lifestyles among Finns and it is intended to follow-up changes
in the health behaviour both at the level of populations and
in distinct population groups. The survey has been carried
out as a postal questionnaire in 1978−2014. The 2010 ran-
dom sample (N = 5000) from the Population Register rep-
resented the whole Finnish working age population from
15 to 64 years. The response rate was 57% (n = 2826) [30].
Self-rated work ability
Self-rated work ability was measured with the use of the
Work Ability Score (WAS), which assesses current work
ability compared to the lifetime best. The respondents were
asked one question: “Assume that your work ability at its
best has a value of 10 points. How many points would you
give your current work ability?” This question is one item
of the Work Ability Index (WAI) [31]. The scores (0–10)
were categorized into four groups according to the recom-
mendation of the designers of the WAI: 0–5 = poor; 6–
7 = moderate; 8–9 = good; and 10 = excellent [32]. The
WAS of Finnish working individuals aged 18–64 years with
type 1 diabetes was compared with the data of the working
general population in Finland of the same age. The
population-level comparison WAS data of working Finnish
people for the year 2009 was obtained from the Finnish
Institute of Occupational Health [Finnish Institute of Occu-
pational Health. Finnish National Work and Health survey,
2009. Unpublished database].
“Finnish National Work and Health” personal inter-
view survey is conducted by the Finnish Institute of Oc-
cupational Health since 1997 [33]. The survey serves as
a national surveillance system on perceived working
conditions and the health of the working-age population.
The random sample (N = 6000) from the Statistics
Finland (the Employment Statistics) represents the
whole Finnish working age population from 20 to
64 years of age (in 2009). The Finnish Institute of Occu-
pational Health has limited the survey only to those who
were working (n = 4516). The response rate was 58%
(n = 2614) [Finnish Institute of Occupational Health.
Finnish National Work and Health survey, 2009. Unpub-
lished database].
Retirement intentions
Retirement intentions were inquired from wage-earners
aged 45–64 years with the question “At what age do you
reckon you will retire on full-time pension?” [34]. The
respondents informed the age in years. The years were
categorized into two groups according to an old-age
pension legislation in Finland (1 = 18–62; 2 = 63–) [35].
The retirement intentions of Finnish wage-earners aged
45–64 years with type 1 diabetes were compared with
the data of the wage-earning population in Finland of
the same age. The population-level comparison data of
retirement intentions of Finnish wage-earners for 2008
were obtained from Statistics Finland [Official Statistics
of Finland (OSF). Quality of work life survey, 2008.
Unpublished database].
“Quality of work life” survey is a personal interview
survey conducted by the Statistics Finland since 1977.
The survey monitors working conditions including work
environments, contents of work, labor market positions
and conditions of employment. The sample (N = 6500)
from the Statistics Finland (the Employment Statistics)
represents the whole Finnish entire wage and salary
earning population from 15 to 64 years of age (in 2008).
The response rate was 68% (n = 4392) [34].
Statistics
We used the FinDM database to assess changes in the
incidence and prevalence estimates of type 1 diabetes
between 1992 and 2007. To derive the incidences, we
calculated the numbers of new cases of type 1 diabetes each
year and divided those numbers by the corresponding
follow-up time measured in person-years in the risk popula-
tion (Fig. 1). An additional file shows this in more detail (see
Additional file 1: Table S1). Prevalence was calculated by
dividing the average number of people with type 1 diabetes
alive during the year by the number of the corresponding
total population. Annual age-standardized rates with 95%
confidence intervals (CI) were computed using the direct
method of standardization, with the European Standard
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Population as the standard population in 1992–2007 (Fig. 2).
An additional file shows this in more detail (see
Additional file 2: Table S2). We derived the incidence and
prevalence figures using stratification by employment status.
A similar standardization method was used to calculate
the age-standardized proportions of working-aged individ-
uals with type 1 diabetes and, correspondingly, percent-
ages of the labor force with type 1 diabetes and employed
individuals with type 1 diabetes among the working-age
general population. The numbers for the general popula-
tion were obtained from Statistics Finland.
The frequencies, percentages, means, standard deviation
(SD) and range were used to describe characteristics of
the participants of the “People with Type 1 Diabetes in
Worklife” survey. An additional file provides more details
[See Additional file 3: Table S3]. The frequencies and per-
centages of SRH and WAS were calculated separately for
working men and women (Fig. 3). The frequencies and
percentages of retirement intentions were calculated only
for 45–64-year-old wage-earning men and women (Fig. 3).
The statistical significance of the difference of distribu-
tions was assessed by chi-squared tests and Fisher’s exact
test. Statistical analyses were carried out in SPSS for Win-
dows, Rel. 21.0.0.1. 2016 (SPSS Inc., Chicago, IL, USA),
and SAS Rel. 9.3 (SAS Institute, Cary, NC, USA) and in R,
version 3.3.1.
a b
Fig. 1 Age-standardized incidence of type 1 diabetes among Finns aged 18–39 years in 1992–2007. a Women; b Men
a b
Fig. 2 Age-standardized percentage of 1) people belonging to the labor force in the general population, 2) employed people in the labor force
in the general population, 3) people belonging to the labor force in T1D-population and 4) employed people in the labor force in T1D-population in
1992–2007. a Women; b Men. T1D = Type 1 diabetes
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Results
Incidence and prevalence of type 1 diabetes among
working-aged individuals in Finland in 1992–2007
The average annual age-standardized incidence rate of
type 1 diabetes among women aged 18–39 years was 16
per 100,000 per year, and it remained at the same level
throughout the 1992–2007 period (Fig. 1). The average
annual age-standardized incidence rate of type 1 diabetes
among men aged 18–39 years was 29 per 100,000 per year,
increasing from 24 (95% CI 21–28) per 100,000 per year
in 1992 to 32 (95% CI 28–37) per 100,000 per year in
2007. This was an increase of 33% over the 15-year period.
On average, 71% of 18–39 aged men and women with in-
cident type 1 diabetes (i.e. who were initially diagnosed
with diabetes within this age range) belonged to the labor
force when diagnosed and 79% of incident cases belonging
to labor force were employed (Fig. 1). An additional file




Fig. 3 Self-rated health, work ability and retirement intentions among working women and men with type 1 diabetes and the general
population. a Self-Rated Health; b Work Ability Score; c Retirement intentions
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The prevalence of type 1 diabetes among working-
aged (18–64 years) people was 541 per 100,000 (95% CI,
533–549) in 1992 and 732 per 100,000 (95% CI, 722–
741) in 2007, representing an increase of 35% over the
15-year period. Among women, the age-standardized
prevalence of type 1 diabetes increased from 449 (95%
CI 438–459) per 100,000 in 1992 to 622 (95% CI 610–
634) per 100,000 in 2007, an increase of 39%. Among
men, the rates were somewhat higher: 631 (95% CI
619–643) in 1992 and 839 (95% CI 825–853) in 2007,
but the numerical increase was less i.e. 33%. [See Additional
file 2: Table S2].
Belonging to the labor force and employment
Between 1992 and 2007, the proportion of people with
type 1 diabetes belonging to the labor force fluctuated
between 58% and 66% for working-aged women and
63% and 69% for working-aged men (Fig. 2). The mean
value of age-standardized proportions was about 10 per-
centage points lower than the corresponding range in
the general population.
During the same period, on average a total of 82% of
individuals with type 1 diabetes belonging to the labor
force were actually employed (Fig. 2). This was very
similar to the value of 84% of individuals in the general
population belonging to labor force who were gainfully
employed. Employment percentages fell to their mini-
mum in 1994 but after that date, the percentages rose.
Among those with type 1 diabetes belonging to the labor
force, 89% of individuals were employed in 2007 whereas
91% of individuals of the general population in the labor
force were employed. Between 1992 and 2007, the total
number of employed individuals with type 1 diabetes
increased by 38% among women and by 34% among
men (Fig. 2). An additional file shows this in more
detail [See Additional file 2: Table S2].
Self-rated health, work ability and intended retirement age
A total of 767 individuals who had been diagnosed with
type 1 diabetes and who had been working during the
past 12 months participated in the “People with Type 1
Diabetes in Worklife” survey. The characteristics of the
participants are shown in Additional file 3: Table S3.
A total of 20% of working women with type 1 diabetes
rated their health as good; this is almost half the corre-
sponding value (37%) of working women in the general
population (Fig. 3). Working women with type 1 dia-
betes were more likely to rate their health slightly more
often as reasonably good, average, rather poor, or poor
than working women in the general population
(p < 0.001). Working men with type 1 diabetes also rated
their health as good less frequently than working men
in the general population. However, they reported
reasonably good and average health more often than
working men in the general population (p < 0.01). The
difference between men and women with type 1 dia-
betes was statistically almost significant (p = 0.083).
A total of 18% of working women with type 1 diabetes
and 15% of working women in the general population
rated their work ability as excellent (Fig. 3). Working
women in the general population were more likely to
assess their work ability as good (69%) than working
women with type 1 diabetes (55%), with the latter
reporting moderate or poor work ability more often
(p < 0.001). The figures were similar among the men
(p < 0.001). There was no significant difference between men
and women with type 1 diabetes in self-rated work ability.
When the assessment was restricted to 45–64-year-old
wage-earners, a total of 41% of female wage-earners with
type 1 diabetes and 34% of female wage-earners in the
general population intended to retire before the age of
63 years (p = NS), (Fig. 3). Similarly, 43% of male wage-
earners with type 1 diabetes intended to retire before the
age of 63 years, a value that was only slightly greater
than the 37% of wage-earning men in the general popu-
lation (p = NS). In general, most of the wage-earners
intended to retire at the age of 63, although about 20%
of the 45–64-year-old wage-earners intended to retire
at the age of 60. There was no statistically significant dif-
ference between men and women with type 1 diabetes
in their intended retirement age.
Discussion
This nationwide study reports register-based data on the
incidence, prevalence, and employment of working-aged
(18–64 years) Finns with type 1 diabetes as well as
survey data on how working individuals with type 1
diabetes perceive their health, work ability and intended
retirement age. The results were compared to the gen-
eral working-age population in Finland.
Incidence of type 1 diabetes among people aged
18–39 years
There is a paucity of knowledge of the incidence rates of
type 1 diabetes among working-aged people and there-
fore we studied incidence in detail. The age-standardized
incidence rates of type 1 diabetes were higher among
men aged 18–39 years compared to women of the same
age. The rates increased by 33% in men over the 15-year
period, while there was no increase among women.
This result corresponds to an earlier study on young
adult Finns aged 15–39 years, which identified a high
incidence of type 1 diabetes and a predominance of
men in these young adults [36]. A predominance of
males has also been found among children under
15 years with type 1 diabetes in Finland [2, 4, 37]. Thus,
a predominance of males seems to be present in various
age groups with type 1 diabetes.
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Among individuals with type 1 diabetes aged 18–
39 years, almost 80% of those belonging to the labor
force were already in paid employment when they were
diagnosed with type 1 diabetes. As far as we are aware,
this is the first investigation into the employment status
of individuals when they were diagnosed with type 1
diabetes. It may be challenging to cope at work when
newly diagnosed with type 1 diabetes. There is evidence
that individuals with type 1 diabetes experience dia-
betes distress [38–40] and work-related diabetes dis-
tress [26], which might impact on their metabolic
control. Trying to combine work and type 1 diabetes
might be especially challenging when an individual is
learning to self-manage diabetes. These challenges
should be studied further and appropriate measures of
support should be developed for working individuals
with recently diagnosed type 1 diabetes.
Prevalence of type 1 diabetes among people aged
18–64 years
We found that during the 15-year period examined, the
age-standardized prevalence of type 1 diabetes in-
creased by 39% among working-aged (18–64 years)
women and 33% among working-aged men i.e. the
increase in prevalence was relatively lower in men. This
result contradicted our finding that incidence rates
have been increasing among men aged 18–39 years, but
not among women of the same age. We suggest that
associations between the prevalence of type 1 diabetes
and the possible causes of the decrease in prevalence
rates at working age – such as death – among working-
aged individuals should be investigated.
While the life expectancy of individuals with type 1
diabetes has been estimated in some countries e.g. in
Scotland and Sweden (loss of life expectancy = ap-
proximately 10–13 years) [41, 42], it has not been inves-
tigated in Finland. However, considerable overall excess
mortality has been reported in insulin-treated Finns [17].
Overall, it is difficult to compare the prevalence rates
of type 1 diabetes among working-aged individuals to
other studies since some of them have reported the
prevalence of type 1 diabetes among children [43], ado-
lescents [44], or the entire population [45], while others
have not separated prevalence into type 1 and type 2
diabetes [46].
Employment
We showed that roughly two out of every three
working-aged individuals with type 1 diabetes belonged
to the labor force, a value about 10 percentage points
less than in general population of Finland. We suggest
that clarifying the causes of this gap would be an
important topic for further research.
We found that employment rates were at the same
level among the labor force with type 1 diabetes and
the general population. In Finland, this is in harmony
with the Non-discrimination Act (1325/2014) [47],
which promotes equality in working life e.g. no dis-
crimination due to a health condition. Thus, workers
with type 1 diabetes should not be discriminated
against because of their diabetes. Unemployment rates
were highest (18-20%) among the labor force in
Finland in 1992–1994. With recovery from the eco-
nomic recession, there was a trend towards greater
employment, year on year until 2007, when the un-
employment rate was about 7% [48]. A similar trend
was seen among individuals with type 1 diabetes.
As said, labor legislation supports equality and we
found no differences in unemployment rates between
the general population and people with type 1 diabetes.
However, a fear of discrimination at work, which might
damage their career prospects, may increase the likeli-
hood of the workers with type 1 diabetes to conceal
their condition and health status [49, 50]. Thus, con-
cealment of type 1 diabetes in working life needs to be
studied further.
Previous results of employment among individuals
with type 1 diabetes are sparse and conflicting. A previ-
ous cross-sectional study from Netherlands showed that
there were similar unemployment rates among em-
ployees with type 1 diabetes as in the general Dutch
population [19]. However, a novel cross-sectional study
from Denmark, based on two surveys, has revealed that
individuals with type 1 diabetes are more frequently un-
employed than the general population of Denmark [13].
In contrast, a repeated cross-sectional study from U.S.
found that women aged 18–65 years with type 1 diabetes
were more likely to be employed than women without
diabetes [18]. This is at odds with a large-scale follow-up
study from Sweden, which stated that women aged 19–
38 years with type 1 diabetes were less likely to be
employed than their peers in the general population
[51]. As far as is known, there are no previous register-
based follow-up studies comparing employment rates
between the whole population with type 1 diabetes and
the general population.
Self-rated health
After excluding people who do not belong to the labor
force, employment among the type 1 diabetes population
is at the same level as in the general population, but
there may nevertheless be work-related issues linked to
type 1 diabetes. In our study, the majority of working
women and men with type 1 diabetes rated their health
as reasonably good. Men with type 1 diabetes were more
frequently likely to report better health than women with
type 1 diabetes. Similar results have been found previously
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in two studies among adults with type 1 diabetes in the
U.S. [52, 53]. We revealed a contradiction in incidence
and prevalence rates between women and men with type
1 diabetes. In our study, the incidence of type 1 diabetes
was higher among men than women in the 1992–2007
period. However, the prevalence of type 1 diabetes in-
creased less among men than among women. It is possible
that those men with type 1 diabetes who feel that their
health is poor leave working life earlier than women.
Overall, women and men with type 1 diabetes rated
their health as good less frequently than women and
men in the general Finnish population. This is not
surprising, given their chronic condition.
Work ability
We assessed self-rated work ability by applying the Work
Ability Score (WAS). There was no gender difference in
WAS rates among workers with type 1 diabetes and the
general population. We have reported previously the same
result by using the Work Ability Index (WAI) among
Finnish workers with type 1 diabetes [23]. Earlier evidence
has demonstrated that this single-item question associates
strongly with the complete WAI [54] and our findings con-
firm this proposal among workers with type 1 diabetes. To
the best of our knowledge, there are no other studies
reporting WAS or WAI among working-aged individuals
with type 1 diabetes. Overall, the prevalence of type 1 dia-
betes has increased among workers in Finland, and workers
with type 1 diabetes reported moderate and poor work abil-
ity slightly more often than the general population. A re-
duced work ability has been found to increase the risk of
long-term sick leaves, disability pension, and unemploy-
ment [55]. In addition, poor work ability and poor general
health increase the risk for dismissal and long-term un-
employment after being made redundant [56]. Thus, special
attention should be paid to those workers with type 1 dia-
betes that report moderate or poor work ability.
Retirement intentions
An interesting finding was that there was no significant
difference in retirement intentions between wage-
earners with type 1 diabetes and the general population.
In both groups, the most frequent (mode) intended re-
tirement age was 63 years. In Finland, at the time of the
data collection of this study people could retire flexibly
on an old-age pension between the ages of 63 and 68. In
addition, a disability pension can be granted for individ-
uals between the ages of 18 and 62 if their work capacity
has been reduced for at least 12 months due to an illness, a
defect or a handicap. A full disability pension can be
awarded if loss of work capacity is at least 60%. In less severe
cases i.e. work capacity reduced by at least 40%, then a par-
tial disability pension can be granted. The disability pension
amounts to only about 60% of an old age pension [35] i.e.
there is no financial incentive for early retirement. As far as
we are aware, this is the first investigation of the retirement
intentions of workers or wage-earners with type 1 diabetes.
However, evidence from Brazil claimed that 4.2% of Brazil-
ian working men and women with type 1 diabetes had re-
tired prematurely due to disabilities [15]. In addition, a study
from the Netherlands – which did not differentiate between
the types of diabetes – showed that workers with diabetes
from 11 European countries had an increased probability of
receiving disability benefits and retiring early. Furthermore,
work-related factors, such as high job demands with low
job control or low rewards, increased the probability of
early retirement among individuals with diabetes [57].
Strengths and limitations
The main strengths of this study were the data covering the
whole Finnish population with type 1 diabetes and the
whole general population from several nationwide registers,
the explicit identification of individuals with type 1 diabetes,
and the long follow-up time (1992–2007). Finland is a
country which houses valid population-based health and
employment registers and these are widely used in epi-
demiological research [35, 37, 48, 58, 59]. Furthermore,
there are comprehensive statistics on work disability factors
such as illnesses, days of absence due to illness [60], and
disability pensions [35]. As a limitation, these registries do
not include any information on individual experiences.
Thus, we complemented register-based information with
the national surveys.
We wanted to describe the greater picture by showing
how people with type 1 diabetes are employed in rela-
tion to the general population and how they manage at
work. Among the key strengths of our survey were the
random sample of 2500 working-aged people with type
1 diabetes, and the large representative national sample
size of 767 working respondents with type 1 diabetes.
The sample represented workers from a wide range of
different organizations and types of work. The response
rate for our survey was 49%, which can be considered as
acceptable [61]. However, selection bias is a typical
phenomenon in these kinds of surveys. In our survey,
the distributions of age and living areas were similar
between respondents and non-respondents, although
women were slightly overrepresented in the sample.
Thus, the sample seems to be truly representative of
working-aged Finns with type 1 diabetes. However, it
cannot be ruled out that the sample is biased according
to some unknown variables, which affect the readiness
to participate, e.g. health status and living habits.
The response rates for the population-level compari-
son data “Health Behaviour and Health among the
Finnish Adult Population” (57%), “Finnish National
Work and Health” (58%), and “Quality of work life”
Hakkarainen et al. BMC Public Health  (2017) 17:805 Page 8 of 11
(68%) were acceptable, but the above-mentioned possi-
bilities for bias may also impact on their validity.
Self-reported questionnaires are commonly used to
gather research data and can be very advantageous in
assessing issues that would be difficult to evaluate with
interviews or objective measurements. We included the
widely used SRH, WAS, and retirement questions in our
survey. The questions were identically phrased in our
“People with Type 1 Diabetes in Worklife” survey and in
the Finnish comparison data. The respondents answered
the same questions within a relatively short time period,
which increases the validity of the comparison between
the populations. Self-reported health and work ability
have been found to be associated significantly with
objective measurements of health, work ability, and
early retirement [27, 28, 54].
The present study has some limitations. First, it can
be challenging to distinguish individuals with type 1
diabetes from individuals with type 2 diabetes of
working-age, so we cannot be completely sure that our
classification which was based on the use of anti-
diabetic medication and age represents a clinically veri-
fied diagnosis. Nonetheless, we are confident that the
cases that we identified are actually being medically-
treated as insulin-dependent patients, so this should
not represent a major limitation. We suggest that fur-
ther register-based follow-up studies are warranted in
other countries because our findings can be generalized
only to Western countries with similar kinds of labor
and health care systems. We also investigated self-rated
health and work ability as well as retirement intentions
in a cross-sectional survey but this setting does not
allow the causes and effects to be evaluated. In addition,
all of the measurements used were self-reported, so recall
bias may have influenced the results.
Conclusions
In conclusion, the number of working-aged people and
workers with type 1 diabetes has clearly increased, and
their self-reported general health and work ability is
rated slightly lower than that of the general population.
There was no significant difference in the retirement in-
tentions of 45–64-year-olds with type 1 diabetes and the
general population of the same age. Thus, it is concluded
that most of the workers with type 1 diabetes seem to
manage at work as well as the general population. How-
ever, special attention should be paid to those individuals
who are working when they are diagnosed with type 1
diabetes and those individuals with type 1 diabetes
reporting moderate or poor work ability. It might be
that serious problems at work accumulate in some
workers with type 1 diabetes due to their condition.
More expertise in health care may be required to identify
workers who need special support as type 1 diabetes
becomes more frequent in the workplace.
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